Increased fibrotic signaling in a murine model for intra-arterial contrast-induced acute kidney injury.
Acute Kidney Injury
/ etiology
Animals
Apoptosis
Carotid Arteries
Cell Hypoxia
Cell Proliferation
Collagen
/ genetics
Contrast Media
/ administration & dosage
Disease Models, Animal
Fibrosis
Gene Expression Regulation
Hypoxia-Inducible Factor 1, alpha Subunit
/ genetics
Injections, Intra-Arterial
Kidney
/ metabolism
Male
Mice, Inbred C57BL
Nephrectomy
Phosphorylation
Receptor, Transforming Growth Factor-beta Type I
/ genetics
Receptor, Transforming Growth Factor-beta Type II
/ genetics
Renal Insufficiency, Chronic
/ complications
Signal Transduction
Smad3 Protein
/ metabolism
Transforming Growth Factor beta1
/ genetics
Triiodobenzoic Acids
/ administration & dosage
animal models
contrast
creatinine
kidney
kidney injury molecule-1
postcontrast acute kidney injury
transforming growth factor-β1/SMAD3 signaling
Journal
American journal of physiology. Renal physiology
ISSN: 1522-1466
Titre abrégé: Am J Physiol Renal Physiol
Pays: United States
ID NLM: 100901990
Informations de publication
Date de publication:
01 05 2020
01 05 2020
Historique:
pubmed:
24
3
2020
medline:
15
7
2020
entrez:
24
3
2020
Statut:
ppublish
Résumé
Contrast-induced acute kidney injury (CI-AKI) is a vexing problem, and more than 70 million patients undergo studies using iodinated contrast. The molecular mechanisms responsible for CI-AKI are poorly understood. The goal of the present article was to determine the role of transforming growth factor-β1 (TGF-β1)/mothers against decapentaplegic homolog (SMAD)3 and associated collagen expression in a murine model of intra-arterial CI-AKI. The murine model of CI-AKI after intra-arterial contrast agent administration was created by first performing a partial nephrectomy to induce chronic kidney disease. Twenty-eight days later, 100 μL of contrast agent [iodixanol (320 mg/mL)] or saline were administered via the carotid artery. Two days after contrast administration, compared with saline, average serum creatinine was significantly elevated (
Identifiants
pubmed: 32200666
doi: 10.1152/ajprenal.00004.2020
pmc: PMC7294333
doi:
Substances chimiques
Contrast Media
0
Hif1a protein, mouse
0
Hypoxia-Inducible Factor 1, alpha Subunit
0
Smad3 Protein
0
Smad3 protein, mouse
0
Tgfb1 protein, mouse
0
Transforming Growth Factor beta1
0
Triiodobenzoic Acids
0
Collagen
9007-34-5
Receptor, Transforming Growth Factor-beta Type I
EC 2.7.11.30
Receptor, Transforming Growth Factor-beta Type II
EC 2.7.11.30
Tgfbr1 protein, mouse
EC 2.7.11.30
Tgfbr2 protein, mouse
EC 2.7.11.30
iodixanol
HW8W27HTXX
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
F1210-F1219Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL098967
Pays : United States
Organisme : NIDDK NIH HHS
ID : R56 DK107870
Pays : United States
Références
Mol Ther. 2019 Sep 4;27(9):1681-1693
pubmed: 31326400
Am J Physiol Renal Physiol. 2011 Oct;301(4):F793-801
pubmed: 21775484
Kidney Int. 1997 Sep;52(3):637-47
pubmed: 9291182
Trends Endocrinol Metab. 2016 Oct;27(10):681-695
pubmed: 27372267
Eur Radiol. 2012 Jun;22(6):1366-71
pubmed: 22307815
Sci Transl Med. 2012 Feb 15;4(121):121ra18
pubmed: 22344686
Cell Physiol Biochem. 2017;41(2):769-783
pubmed: 28214834
Clin Sci (Lond). 2016 Apr 1;130(7):525-38
pubmed: 26733721
Curr Opin Oncol. 2007 Nov;19(6):579-85
pubmed: 17906455
Nephrol Dial Transplant. 2005 Feb;20 Suppl 1:i6-11
pubmed: 15705946
Invest Radiol. 1999 Nov;34(11):685-91
pubmed: 10548380
Exp Suppl. 2018;108:177-210
pubmed: 30536172
Nephrol Dial Transplant. 2007 May;22(5):1323-31
pubmed: 17308324
World J Nephrol. 2013 Aug 6;2(3):84-9
pubmed: 24255890
Mayo Clin Proc. 2015 Aug;90(8):1046-53
pubmed: 26250726
Radiology. 2019 Sep;292(3):664-672
pubmed: 31264950
J Am Soc Nephrol. 2003 May;14(5):1358-73
pubmed: 12707406
J Vasc Interv Radiol. 2011 Aug;22(8):1159-65
pubmed: 21570871
Contrib Nephrol. 2011;169:37-50
pubmed: 21252510
Am J Physiol Renal Physiol. 2002 Dec;283(6):F1326-36
pubmed: 12388382
Eur Radiol. 2018 Jul;28(7):2845-2855
pubmed: 29426991
Crit Rev Biochem Mol Biol. 2002 Dec;37(6):375-536
pubmed: 12540195
Eur Radiol. 2018 Dec;28(12):5384-5395
pubmed: 30132106
J Am Soc Nephrol. 2014 Jan;25(1):65-80
pubmed: 24158985
Invest Radiol. 2016 Dec;51(12):804-809
pubmed: 27299579
J Clin Invest. 2011 Nov;121(11):4210-21
pubmed: 22045571
Nephrol Dial Transplant. 2018 Aug 1;33(8):1317-1319
pubmed: 29868731
Nat Rev Nephrol. 2010 Nov;6(11):679-88
pubmed: 20877303
Ann Emerg Med. 2017 May;69(5):577-586.e4
pubmed: 28131489
PLoS One. 2014 Apr 14;9(4):e94510
pubmed: 24732590
Eur Radiol. 2013 Feb;23(2):319-23
pubmed: 22895617
Nephron Extra. 2013 Jun 06;3(1):50-8
pubmed: 23898346
Rev Cardiovasc Med. 2003;4 Suppl 5:S3-9
pubmed: 14668704
Inflamm Regen. 2018 Aug 06;38:14
pubmed: 30123390
Invest Radiol. 2013 Apr;48(4):175-82
pubmed: 23262792
J Clin Invest. 2002 Nov;110(10):1525-38
pubmed: 12438450
Kidney Int. 1996 May;49(5):1268-75
pubmed: 8731090
Sci Rep. 2018 Apr 26;8(1):6630
pubmed: 29700311
Front Physiol. 2015 Mar 19;6:82
pubmed: 25852569